Rocket Pharmaceuticals Prices $175M Public Offering Of 7,812,500 Common Shares At $16/Share, And Pre-Funded Warrants To Purchase 3,126,955 Common Shares At $15.99/Pre-Funded Warrant
Portfolio Pulse from Benzinga Newsdesk
Rocket Pharmaceuticals has priced its public offering of 7,812,500 common shares at $16 per share, and pre-funded warrants to purchase 3,126,955 common shares at $15.99 per pre-funded warrant, raising a total of $175 million.
September 13, 2023 | 6:36 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Rocket Pharmaceuticals' public offering could dilute existing shareholders' equity, potentially leading to a short-term decrease in stock price.
Public offerings often lead to equity dilution for existing shareholders, which can result in a short-term decrease in stock price. However, the raised capital could be used for beneficial long-term investments.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100